(EVK) Evonik Industries - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000EVNK013
EVK: Additives, Resins, Amino, Acids, Catalysts, Polymers
Evonik Industries AG is a global leader in the specialty chemicals sector, operating across Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. With a history dating back to 1873, the company has established itself as a key player in multiple high-value markets, making it a significant consideration for investors and fund managers looking for exposure to the specialty chemicals industry.
The company’s operations are organized into five distinct segments, each addressing specific industrial and consumer needs. The Specialty Additives segment is a cornerstone of Evonik’s business, providing critical additives for polyurethane, coatings, adhesives, and lubricants. These products are essential for enhancing the performance and durability of materials used in construction, automotive, and industrial applications. This segment’s offerings include isophorone and epoxy curing agents, which are vital for coatings and composites, as well as pour-point depressants and viscosity index improvers for lubricants.
The Nutrition & Care segment highlights Evonik’s role in addressing health and sustainability trends. It supplies amino acids like D-/l-methionine and lysine for the animal nutrition industry, which are critical for optimizing livestock health and feed efficiency. Additionally, this segment provides pharmaceutical active ingredients and biocompatible materials for medical applications, aligning with growing demand for advanced healthcare solutions. It also offers system solutions for cosmetics and detergents, catering to consumer goods industries focused on sustainability and performance.
The Smart Materials segment underscores Evonik’s commitment to innovation in high-performance materials. This segment produces inorganic materials such as fumed and precipitated silicas and silanes, which are used in a variety of applications, including rubber, plastics, and electronics. It also offers peroxides for the paper and textile industries, as well as specialty catalysts and polymers like polyamide 12, which are essential for advanced manufacturing processes. These materials play a crucial role in enabling the production of lightweight, durable, and high-performance products.
The Performance Materials segment focuses on C4 derivatives and superabsorbent products. C4 derivatives, such as butadiene and MTBE, are key intermediates in the production of tires, adhesives, and plastics, making this segment vital to the automotive and industrial sectors. Superabsorbent polymers, on the other hand, are used in hygiene products like diapers, demonstrating Evonik’s ability to meet everyday consumer needs while maintaining a strong industrial focus.
The Technology & Infrastructure segment rounds out Evonik’s offerings by providing essential services that ensure operational efficiency and innovation. This includes energy management, plant maintenance, process safety, and logistics solutions, as well as digital tools for optimizing chemical production. By integrating these capabilities, Evonik strengthens its competitive position and supports its customers in achieving operational excellence.
From a financial perspective, Evonik Industries AG offers an attractive profile for investors. With a market capitalization of €9,366.60 million, the company provides a blend of stability and growth potential. Its forward P/E ratio
Additional Sources for EVK Stock
EVK Stock Overview
Market Cap in USD | 10,525m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
EVK Stock Ratings
Growth 5y | -2.54% |
Fundamental | 0.33% |
Dividend | 80.3% |
Rel. Strength | 21 |
Analysts | - |
Fair Price Momentum | 21.56 EUR |
Fair Price DCF | 40.18 EUR |
EVK Dividends
Dividend Yield 12m | 11.97% |
Yield on Cost 5y | 14.44% |
Annual Growth 5y | 0.35% |
Payout Consistency | 96.7% |
EVK Growth Ratios
Growth Correlation 3m | 90.9% |
Growth Correlation 12m | 8.7% |
Growth Correlation 5y | -39.1% |
CAGR 5y | 4.35% |
CAGR/Max DD 5y | 0.11 |
Sharpe Ratio 12m | 0.84 |
Alpha | 0.93 |
Beta | 1.030 |
Volatility | 29.45% |
Current Volume | 740.3k |
Average Volume 20d | 1274.3k |
As of April 03, 2025, the stock is trading at EUR 20.11 with a total of 740,324 shares traded.
Over the past week, the price has changed by -3.04%, over one month by +4.17%, over three months by +20.31% and over the past year by +16.19%.
Neither. Based on ValueRay Fundamental Analyses, Evonik Industries is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.33 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EVK as of April 2025 is 21.56. This means that EVK is currently overvalued and has a potential downside of 7.21%.
Evonik Industries has no consensus analysts rating.
According to ValueRays Forecast Model, EVK Evonik Industries will be worth about 24 in April 2026. The stock is currently trading at 20.11. This means that the stock has a potential upside of +19.29%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 21.9 | 9.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 24 | 19.3% |